Q999--Nitric Oxide/Inotherapy

Posted Date: Mar 02, 2026
Apr 01, 2026
Awarded Date: Feb 26, 2026
SetAside Type
Solicitation ID Solicitation Title Solicitation Office
6912620210176 Q999--Nitric Oxide/Inotherapy
Synopsis
The Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System (VAGLAHS) has awarded a contract for nitric oxide-based inhalation therapy which is being used for patient care to treat patients with acute respiratory distress syndrome (ARDS), as well as acute pulmonary hypertension. INO Therapeutics LLC is the manufacturer and sole provider of the current INOtherapy System, INOmax DSIR® Plus delivery system, INOmax® (nitric oxide) for inhalation, and accompanying services and products in the United States. It was determined that no other contractor can provide a system with the same state-of-the-art capabilities. The INOtherapy System offers proprietary technology including the .... Read More
Office Location Agency Name Solicitation Base Posting Type
VETERANS AFFAIRS, DEPARTMENT OF AWARD Notice
An error has occurred. This application may no longer respond until reloaded. Reload 🗙